Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „Pomalidomide“
Suchtreffer
Begriffe & Kennungen
Pomalidomide Zentiva · 4.8 · Haemorrhage Haemorrhagic disorders have been reported with pomalidomide, especially in patients with risk fact
Eintrag öffnenPomalidomide Zentiva · 4.8 · Infection occurred in 83.1% (Pom+Btz+Dex) patients and 55.0% (Pom+Dex) patients [34.9% (Pom+Btz+Dex) and 24.0%
Eintrag öffnenPomalidomide Zentiva · 4.8 · Neutropenia and thrombocytopenia Neutropenia occurred in up to 54.0% (Pom+Btz+Dex) of patients [47.1% (Pom+Btz
Eintrag öffnenPomalidomide Zentiva · 4.8 · Neutropenia and thrombocytopenia tended to occur more frequently within the first 2 cycles of treatment with p
Eintrag öffnenPomalidomide Zentiva · 4.8 · Paediatric population Adverse reactions reported in paediatric patients (aged 4 to 18 years) with recurrent or
Eintrag öffnenPomalidomide Zentiva · 4.8 · Peripheral neuropathy - Pomalidomide in combination with bortezomib and dexamethasone Patients with ongoing pe
Eintrag öffnenPomalidomide Zentiva · 4.8 · Peripheral neuropathy - Pomalidomide in combination with dexamethasone Patients with ongoing peripheral neurop
Eintrag öffnenPomalidomide Zentiva · 4.8 · Pomalidomide in combination with bortezomib and dexamethasone The most commonly reported blood and lymphatic s
Eintrag öffnenPomalidomide Zentiva · 4.8 · Pomalidomide in combination with dexamethasone The most commonly reported adverse reactions in clinical studie
Eintrag öffnenPomalidomide Zentiva · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenPomalidomide Zentiva · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenPomalidomide Zentiva · 4.8 · Summary of the safety profile
Eintrag öffnenPomalidomide Zentiva · 4.8 · Table 7. Adverse reactions (ADRs) reported in clinical trials and post-market settings Combination of treatmen
Eintrag öffnenPomalidomide Zentiva · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenPomalidomide Zentiva · 4.8 · Teratogenicity Pomalidomide is structurally related to thalidomide. Thalidomide is a known human teratogenic a
Eintrag öffnenPomalidomide Zentiva · 4.8 · The adverse reactions observed in patients treated with pomalidomide in combination with bortezomib and dexame
Eintrag öffnenPomalidomide Zentiva · 4.8 · The frequencies in this section are from clinical studies in patients receiving pomalidomide treatment in comb
Eintrag öffnenPomalidomide Zentiva · 4.8 · Thrombocytopenia occurred in 39.9% (Pom+Btz+Dex) patients and 27.0% (Pom+Dex) patients. Thrombocytopenia was G
Eintrag öffnenPomalidomide Zentiva · 4.8 · Thromboembolic events Prophylaxis with acetylsalicylic acid (and other anticoagulants in high risk patients) w
Eintrag öffnenPomalidomide Zentiva · 4.8 · Venous thromboembolic events (VTE) occurred in 12.2% (Pom+Btz+Dex) patients and 3.3% (Pom+Dex) patients [5.8%
Eintrag öffnen